Juvisé Pharmaceuticals

Juvis?© Pharmaceuticals Successfully Complete a €400M Refinancing Following the Acquisition of the Worldwide Rights of Pylera

Paris, France, July 5, 2022: The French speciality pharmaceutical company, JuvisÈ Pharmaceuticals has recently completed a transaction with AbbVie, regarding the acquisition of the worldwide commercial rights of Pylera. Details of this transaction remain undisclosed.
28 rue Bayard 75008 Paris

+33 (0)4 26 29 40 00